Table 2.
Frequency of community pharmacists’ self-reported practices in supplying non-steroidal anti-inflammatory drugs (NSAIDs)
| No. of community pharmacists (%) | ||||
|---|---|---|---|---|
| Practice roles | Regularly a | Occasionally b | Never c | Total |
| Screening for risk factors | ||||
| For non-selective NSAIDs | 150 (95.5) | 7 (4.5) | 0 (0) | 157 (100.0) |
| For selective COX-2 NSAIDs | 85 (56.3) | 61 (40.4) | 5 (3.3) | 151 (100.0) |
| Assessment of the necessity for using NSAIDs | 109 (70.3) | 43 (27.7) | 3 (1.9) | 155 (100.0) |
| ADR communication | ||||
| For non-selective NSAIDs | 98 (63.2) | 56 (36.1) | 1 (0.7) | 155 (100.0) |
| For selective COX-2 NSAIDs | 55 (36.9) | 86 (57.7) | 8 (5.4) | 149 (100.0) |
| Advice to manage and prevent adverse effects | ||||
| For non-selective NSAIDs | 118 (79.7) | 28 (18.9) | 2 (1.4) | 148 (100.0) |
| For selective COX-2 NSAIDs | 86 (58.9) | 57 (39.0) | 3 (2.1) | 146 (100.0) |
| Asking about current drug use/herbs/supplements | 48 (30.8) | 95 (60.9) | 13 (8.3) | 156 (100.0) |
| Advice on what should/should not do while taking NSAIDs | 116 (73.4) | 41 (26.0) | 1 (0.6) | 158 (100.0) |
COX=cyclooxygenase.
a
Regularly was defined as providing practice to all patients.
b
Occasionally was defined as providing practice to some patients.
c
Never was defined as not providing practice to all patients.